Moneycontrol PRO
HomeNewsBusinessStocksShivalik Rasayan zooms 5% despite US FDA observations on Bharuch unit

Shivalik Rasayan zooms 5% despite US FDA observations on Bharuch unit

Shivalik Rasayan share price | The share touched a 52-week high of Rs 890.05 and a 52-week low of Rs 498.00 on 07 August, 2023 and 14 March, 2024, respectively.

April 10, 2024 / 10:10 IST
Shivalik Rasayan
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    The share price of Shivalik Rasayan rallied 5 percent in the early trade on April 10 despite US FDA issuing seven observations for its Bharuch facility.

    At 9:22am, Shivalik Rasayan was quoting Rs 594, up Rs 30.25, or 5.37 percent, on the BSE.

    The United States Food and Drug Administration (US FDA) inspected the API facility of Shivalik Rasayan at Plot No D-2/CH/41/A, Dahej- II, Industrial Estate Village- Vaddala Taluka-Vagra, Bharuch, Gujarat from April 1, 2024 and concluded on April 9, 2024, the company said.

    The inspection closed successfully with seven observations. These observations are procedural in nature and will be responded within the stipulated time, the company said.

    Catch all market action in our live blog

    The share touched a 52-week high of Rs 890.05 and a 52-week low of Rs 498.00 on August 7, 2023 and March 14, 2024. Currently, the stock is trading 33.26 percent below its 52-week high and 19.28 percent above its 52-week low.

    Moneycontrol News
    first published: Apr 10, 2024 09:39 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347